* CEO Weldon recovering from back surgery
* Another J&J official prepared to testify instead
* House committee says hearing still on
WASHINGTON, May 19 U.S. House lawmakers will
not hear from Johnson & Johnson (JNJ.N) chief executive William
Weldon at next week's hearing on recalled children's products,
as he recovers from back surgery.
J&J spokeswoman Carol Goodrich said Weldon had surgery on
Wednesday, but was willing to communicate with the House
Oversight and Government Reform Committee about the recalled
Tylenol and other products at a later date.
J&J's Worldwide Chairman of the Consumer Group Colleen
Goggins is prepared to testify instead, Goodrich said.
Despite calls from some Republicans to postpone the
hearing, Democratic Chairman Edolphus Towns said earlier on
Wednesday the May 27 hearing would go on as scheduled.
The hearing comes after J&J announced a widespread recall
of its liquid Tylenol, Motrin, Benadryl and Zyrtec products for
infants and children on April 30. FDA later announced agency
investigators had uncovered numerous violations at the
company's Fort Washington, Pennsylvania plant.
Lawmakers have also invited U.S. Food and Drug
Administration Commissioner Margaret Hamburg to testify, but an
agency spokeswoman could not confirm whether Hamburg would
(Reporting by Susan Heavey; editing by Andre Grenon)